Hadassah Ein-Karem

Jerusalem 91120

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Refractory Metastatic Gastric Cancer

Studies at this site

• Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma — Completed
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed